Zeto Unveils NeuroPulse, the First AI-Powered Status Epilepticus Software Using Full 10-20 EEG in Collaboration with encevis
SANTA CLARA, Calif., April 2, 2025 /PRNewswire/ — Zeto, Inc., a fast-growing medical technology company revolutionizing EEG diagnostics with its cutting-edge devices and advanced cloud platform, announces the integration of live bedside AI-powered Seizure Burden and Status Epilepticus detection. Utilizing encevis, a leading FDA-cleared EEG analysis software developed by the Austrian Institute of Technology, this new capability enhances EEG monitoring with automated detection and notifications for Status Epilepticus—a life-threatening, prolonged seizure condition requiring immediate intervention.
